Order Article Reprints

Weinelt FA, Stegemann MS, Theloe A, Pfäfflin F, Achterberg S, Weber F, Dübel L, Mikolajewska A, Uhrig A, Kiessling P, et al. Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools. Antibiotics. 2022; 11(6):758. https://doi.org/10.3390/antibiotics11060758

Weinelt, Ferdinand Anton, Miriam Songa Stegemann, Anja Theloe, Frieder Pfäfflin, Stephan Achterberg, Franz Weber, Lucas Dübel, Agata Mikolajewska, Alexander Uhrig, Peggy Kiessling, and et al. 2022. "Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools" Antibiotics 11, no. 6: 758. https://doi.org/10.3390/antibiotics11060758

Weinelt, F. A., Stegemann, M. S., Theloe, A., Pfäfflin, F., Achterberg, S., Weber, F., Dübel, L., Mikolajewska, A., Uhrig, A., Kiessling, P., Huisinga, W., Michelet, R., Hennig, S., & Kloft, C. (2022). Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools. Antibiotics, 11(6), 758. https://doi.org/10.3390/antibiotics11060758